Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00215
Species: Homo sapiens
Position : chr6:30754822-30755196
Year: 2016
Title: A New Class of Temporarily Phenotypic Enhancers Identified by CRISPR/Cas9 Mediated Genetic Screening
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: ovarian carcinoma
PMID:  26818394
MONDO: MONDO:0005140
Tissue: Ovary
Tissue Ontology ID: UBERON:0000992
Cell Source: OVCAR3
CVCL ID: CVCL_0465
Cell Type: ovarian carcinoma cell
Cell Ontology ID: CL:0000069
Experiment Type: Functional perturbation assay, Enhancer activity assay
High Throughput Method: ChIP-seq, RNA-seq, 4C-seq
Low Throughput Method: CRISPR Knockout, CRISPRi, Luciferase Reporter Assay, RT-RT-qPCR
About Target Gene
Target gene :
About TF
TF name : POU5F1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU5F1 HIF-2-alpha transcription factor network pid 34
POU5F1 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
POU5F1 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
POU5F1 Transcriptional regulation of pluripotent stem cells reactome 28
POU5F1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
POU5F1 Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 wikipathways 12
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01207 chr6:30754822-30755196 Inner cell mass embryonic stem cell --
Expression of Target Genes for the Enhancer